Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women; cross-sectional study


Autoria(s): Stocco, Bianca; Fumagalli, Helen Figueiredo; Franceschini, Silvio Antonio; Martinez, Edson Zangiacomi; Marzocchi-Machado, Cleni Mara; Torqueti Toloi, Maria Regina
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

31/10/2013

31/10/2013

02/08/2013

Resumo

Background: The objective of this study was to evaluate the effect of three contraceptive pills containing ethinylestradiol (EE) (20 or 30 mcg) in combination with drospirenone (DRSP) and levonorgestrel (LNG) on plasma concentration of adhesion molecules vascular cell adhesion molecule -1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and E-selectin. Study Design: A cross-sectional study was conducted with 72 participants (18-30 years old) distributed into three groups that used oral contraceptives containing EE 20 or 30 mcg combined with DRSP 3 mg or EE 30 mcg/LNG 150 mcg for at least 6 months. The control group was comprised of nonusers of contraceptives. Soluble VCAM-1, soluble ICAM-1 and soluble E-selectin were evaluated by enzyme-linked immunosorbent assay. Results: Compared to the control group, a significant decrease was found in VCAM-1 and ICAM-1 concentrations with use of DRSP/20 EE and LNG/30 EE. Conclusions: DRSP/20 EE and LNG/30 EE induce favorable changes in endothelial function. (C) 2012 Elsevier Inc. All rights reserved.

FAPESP, Brazil [07/58578-7]

FAPESP (Brazil)

Foundation for Research Support of Sao Paulo

Foundation for Research Support of Sao Paulo

Identificador

CONTRACEPTION, NEW YORK, v. 86, n. 5, supl. 1, Part 4, pp. 506-510, NOV, 2012

0010-7824

http://www.producao.usp.br/handle/BDPI/37060

10.1016/j.contraception.2012.03.013

http://dx.doi.org/10.1016/j.contraception.2012.03.013

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE INC

NEW YORK

Relação

CONTRACEPTION

Direitos

closedAccess

Copyright ELSEVIER SCIENCE INC

Palavras-Chave #COMBINED ORAL CONTRACEPTIVES #ADHESION MOLECULES #DROSPIRENONE #ATHEROSCLEROSIS #HEALTHY POSTMENOPAUSAL WOMEN #REPLACEMENT THERAPY #HORMONE-THERAPY #E-SELECTIN #DISEASE #ATHEROSCLEROSIS #MECHANISMS #MARKERS #RISK #OBSTETRICS & GYNECOLOGY
Tipo

article

original article

publishedVersion